Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
ViroMissile, Inc.
University of Nebraska
Guerbet
Tanabe Pharma America, Inc.
Travera Inc
Jonsson Comprehensive Cancer Center
University Health Network, Toronto